Trial Profile
Phase I/II Study of TLR7 Agonist Imiquimod and Radiotherapy in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Cyclophosphamide
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 20 Dec 2018 Status changed from active, no longer recruiting to completed.
- 05 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 16 Feb 2017 Planned End Date changed from 1 Sep 2018 to 1 Feb 2019.